Press release
Cell and Gene Therapy Contract Development and Manufacturing Organization Market key players 2026-2034: Omnicell, Koninklijke Philips, DrFirst.com etc
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00040769?utm_source=OpenPR&utm_medium=10770
Cell and Gene Therapy Contract Development and Manufacturing Organization Market Analysis
The Cell and Gene Therapy Contract Development and Manufacturing Organization Market Analysis highlights exceptional growth potential driven by technological advancements, increasing clinical trials, and rising regulatory approvals of cell and gene therapies. The market size is projected to reach US$ 31.86 billion by 2031 from US$ 6.22 billion in 2024, registering a remarkable CAGR of 26.4% during 2025-2031. This exponential growth reflects the growing reliance of biotechnology and pharmaceutical companies on specialized manufacturing partners to accelerate time-to-market and manage complex production requirements.
The surge in demand for outsourcing services is primarily attributed to the high cost and technical complexity associated with in-house manufacturing of cell and gene therapies. Contract development and manufacturing organizations provide end-to-end services, including process development, clinical manufacturing, commercial production, and regulatory support, making them indispensable partners in the biopharmaceutical value chain.
Market Overview
The Cell and Gene Therapy Contract Development and Manufacturing Organization Market encompasses a wide range of services tailored to support the development and commercialization of advanced therapies. These services include viral vector manufacturing, cell processing, plasmid DNA production, and analytical testing. The increasing number of pipeline therapies, particularly in oncology and rare diseases, is significantly boosting the demand for contract manufacturing services.
Cell therapies, including CAR-T and stem cell therapies, are gaining traction due to their potential to provide long-term or curative outcomes. Similarly, gene therapies are revolutionizing treatment approaches by addressing the root cause of genetic disorders. However, these therapies require highly specialized infrastructure, stringent regulatory compliance, and sophisticated supply chain management, which has led to increased outsourcing to experienced contract development and manufacturing organizations.
Geographically, North America dominates the market due to its well-established biopharmaceutical ecosystem, strong presence of leading contract development and manufacturing organizations, and favorable regulatory environment. Europe also holds a significant share, supported by increasing research activities and government funding. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth, driven by expanding biotechnology sectors, lower manufacturing costs, and rising investments in healthcare infrastructure.
Explore full report: https://www.theinsightpartners.com/reports/cell-and-gene-therapy-contract-development-and-manufacturing-organization-market
Key Market Drivers
Several factors are contributing to the rapid growth of the Cell and Gene Therapy Contract Development and Manufacturing Organization Market:
• Rising Number of Clinical Trials: Increasing clinical research in cell and gene therapies is driving demand for specialized manufacturing services.
• Technological Advancements: Innovations in viral vector production, gene editing technologies, and automation are enhancing manufacturing efficiency.
• Growing Outsourcing Trend: Biopharmaceutical companies are focusing on core competencies while outsourcing complex manufacturing processes.
• Regulatory Support: Accelerated approval pathways and orphan drug designations are encouraging the development of advanced therapies.
• Investment Growth: Increasing funding from public and private sectors is supporting research and commercialization efforts.
Market Challenges
Despite strong growth prospects, the market faces several challenges:
• High capital investment required for advanced manufacturing facilities
• Complex and evolving regulatory frameworks across regions
• Limited skilled workforce for handling specialized manufacturing processes
• Supply chain constraints, particularly for viral vectors and raw materials
Top Key Players
The Cell and Gene Therapy Contract Development and Manufacturing Organization Market is highly competitive, with key players focusing on capacity expansion, strategic partnerships, and technological innovation. Prominent companies include:
• Lonza Group AG
• Catalent, Inc.
• Thermo Fisher Scientific Inc.
• Samsung Biologics
• WuXi AppTec
• Charles River Laboratories International, Inc.
• Fujifilm Diosynth Biotechnologies
• AGC Biologics
• Oxford Biomedica plc
• Cytiva (Danaher Corporation)
Emerging Trends
The market is evolving rapidly with several notable trends shaping its future:
• Expansion of Viral Vector Manufacturing: Increased demand for viral vectors used in gene therapies
• Adoption of Automation and Digitalization: Enhancing efficiency and reducing human error in manufacturing processes
• Strategic Collaborations: Partnerships between contract development and manufacturing organizations and biotech firms to accelerate innovation
• Focus on Personalized Medicine: Growing demand for patient-specific therapies requires flexible manufacturing solutions
• Capacity Expansion Initiatives: Companies are investing heavily in new facilities to meet rising demand
Purchase a Copy of this report:
https://www.theinsightpartners.com/buy/TIPRE00040769?utm_source=OpenPR&utm_medium=10770
Future Outlook
The future of the Cell and Gene Therapy Contract Development and Manufacturing Organization Market appears highly promising, with sustained growth expected over the forecast period. As the pipeline of advanced therapies continues to expand, the need for specialized manufacturing capabilities will increase significantly. Contract development and manufacturing organizations will play a crucial role in bridging the gap between research and commercialization by providing scalable and compliant solutions.
Emerging technologies such as gene editing, next-generation sequencing, and artificial intelligence are expected to further enhance manufacturing efficiency and precision. Additionally, the increasing focus on personalized medicine and targeted therapies will drive demand for flexible and modular manufacturing platforms.
The expansion of manufacturing capacities in emerging markets, coupled with supportive regulatory frameworks, will create new growth opportunities for market players. As competition intensifies, companies are likely to focus on innovation, quality, and strategic partnerships to maintain their competitive edge.
Related Reports:
Oncology Clinical Trials Market- https://www.theinsightpartners.com/reports/oncology-clinical-trials-market
Medication Adherence Market - https://www.theinsightpartners.com/reports/medication-adherence-market
Contact Us
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us
The Insight Partners is a leading provider of actionable market intelligence and consulting services across various industries. Our research reports combine advanced analytics, expert insights, and reliable data to help organizations identify new opportunities, optimize strategies, and achieve sustainable growth. We specialize in delivering in-depth market studies covering healthcare, technology, manufacturing, and emerging sectors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Contract Development and Manufacturing Organization Market key players 2026-2034: Omnicell, Koninklijke Philips, DrFirst.com etc here
News-ID: 4483781 • Views: …
More Releases from The Insight Parntners
Live Cell Shipper Market to Reach Significant Valuation by 2034, Driven by Risin …
The Live Cell Shipper Market is witnessing significant transformation as advancements in biotechnology, regenerative medicine, and cell and gene therapies continue to expand globally. Live cell shipping solutions are essential for maintaining the viability of biological samples, including living cells, tissues, and clinical materials, during transportation across research institutes, pharmaceutical companies, and diagnostic laboratories. The increasing demand for temperature-controlled and cryogenic logistics has positioned the Live Cell Shipper Market as…
Bio-Electronics Market to Reach US$ 33.16 Billion by 2034, Growing from US$ 14.3 …
The global Bio-Electronics Market is witnessing significant transformation, driven by the convergence of biotechnology, electronics, and medical sciences. Bio-electronics refers to the integration of biological systems with electronic devices to monitor, diagnose, and treat medical conditions more effectively. These technologies are increasingly being adopted in applications such as implantable devices, wearable health monitors, neural implants, and regenerative medicine solutions. With the rising prevalence of chronic diseases, aging populations, and increasing…
Organoids Market to Grow Rapidly by 2031 Driven by 3D Cell Culture and Drug Disc …
The Organoids Market is experiencing significant expansion due to its rising adoption in biomedical research, regenerative medicine, and drug discovery applications. Organoids, which are miniature and simplified versions of organs grown in vitro, have revolutionized preclinical testing by providing more accurate human tissue models compared to traditional 2D cell cultures.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00017616?utm_source=OpenPR&utm_medium=10770
The global Organoids Market size is projected to reach US$ 15.01 billion by 2031 from US$ 3.03…
Global Mirna Kits Market Size is Anticipated to reach US$ 8.76 Billion by 2034
The global MiRNA Kits Market is experiencing significant momentum as the demand for advanced molecular biology tools continues to rise across research institutes, diagnostic laboratories, and pharmaceutical companies. MicroRNA (miRNA) kits play a crucial role in isolating, quantifying, and analyzing small non-coding RNA molecules that regulate gene expression. These kits are increasingly being used in oncology research, infectious disease studies, and genetic disorder analysis, making them an essential component of…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
